Qiuyun Wang

Title: Qiuyun Wang: Innovator in RNA Therapeutics

Introduction

Qiuyun Wang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of RNA therapeutics, particularly in the development of methods for inhibiting specific gene expressions related to inflammation-related diseases.

Latest Patents

One of his key patents is titled "Compositions and methods for inhibiting expression of ADAMTS-5 and ADAM17." This patent involves the use of siRNAs or chemically-modified siRNAs that target ADAMTS-5 or ADAM17 to inhibit their expression. The application of these siRNAs is particularly relevant for treating diseases associated with ADAMTS-5 or ADAM17, such as arthritis and other inflammation-related conditions. The method includes injecting the siRNAs or preparations containing the siRNAs into the articular cavity of patients.

Career Highlights

Qiuyun Wang has worked with prestigious institutions, including the Chinese Academy of Sciences and Guangzhou Ribobio Co., Ltd. His work has been instrumental in advancing the understanding and treatment of inflammation-related diseases through innovative RNA-based therapies.

Collaborations

Some of his notable coworkers include Bill Biliang Zhang and Micky D Tortorella, who have collaborated with him on various research projects.

Conclusion

Qiuyun Wang's contributions to RNA therapeutics highlight his role as an innovator in the field. His work continues to pave the way for new treatment options for patients suffering from inflammation-related diseases.